NZ234004A - Crystalline, enterally absorbable salts of alpha-(2,2-dimethylpropanoyloxy)ethyl 7-(2-(2-aminothiazol-4-yl)-2-(z)-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate; pharmaceutical preparation and process for preparation - Google Patents

Crystalline, enterally absorbable salts of alpha-(2,2-dimethylpropanoyloxy)ethyl 7-(2-(2-aminothiazol-4-yl)-2-(z)-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate; pharmaceutical preparation and process for preparation

Info

Publication number
NZ234004A
NZ234004A NZ234004A NZ23400490A NZ234004A NZ 234004 A NZ234004 A NZ 234004A NZ 234004 A NZ234004 A NZ 234004A NZ 23400490 A NZ23400490 A NZ 23400490A NZ 234004 A NZ234004 A NZ 234004A
Authority
NZ
New Zealand
Prior art keywords
cephem
ethyl
hydroxyimino
acetamido
dimethylpropanoyloxy
Prior art date
Application number
NZ234004A
Other languages
English (en)
Inventor
Friedhelm Adam
Walter Durckheimer
Burkhard Mencke
Dieter Isert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NZ234004A publication Critical patent/NZ234004A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ234004A 1989-06-13 1990-06-11 Crystalline, enterally absorbable salts of alpha-(2,2-dimethylpropanoyloxy)ethyl 7-(2-(2-aminothiazol-4-yl)-2-(z)-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate; pharmaceutical preparation and process for preparation NZ234004A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3919259A DE3919259A1 (de) 1989-06-13 1989-06-13 Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
NZ234004A true NZ234004A (en) 1992-07-28

Family

ID=6382651

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ234004A NZ234004A (en) 1989-06-13 1990-06-11 Crystalline, enterally absorbable salts of alpha-(2,2-dimethylpropanoyloxy)ethyl 7-(2-(2-aminothiazol-4-yl)-2-(z)-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate; pharmaceutical preparation and process for preparation

Country Status (19)

Country Link
US (1) US5409918A (da)
EP (1) EP0402806B1 (da)
JP (1) JPH0730085B2 (da)
KR (1) KR0158883B1 (da)
CN (1) CN1043043C (da)
AT (1) ATE95185T1 (da)
AU (1) AU645254B2 (da)
CA (1) CA2018794C (da)
DE (2) DE3919259A1 (da)
DK (1) DK0402806T3 (da)
ES (1) ES2045653T3 (da)
FI (1) FI96424C (da)
HU (1) HU207087B (da)
IE (1) IE64076B1 (da)
IL (1) IL94701A (da)
NO (1) NO174258C (da)
NZ (1) NZ234004A (da)
PT (1) PT94347B (da)
ZA (1) ZA904526B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU48484B (sh) * 1991-05-24 1998-09-18 Hoechst Aktiengesellschaft Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline
US5589593A (en) * 1991-11-11 1996-12-31 Biochimica Opos Spa Crystalline form of a cephalosporin antibiotic
TW212181B (da) * 1992-02-14 1993-09-01 Hoechst Ag
ES2117066T3 (es) * 1992-05-21 1998-08-01 Hoechst Ag Procedimiento para la disociacion de esteres profarmacos de cefalosporina para dar acido 7-amino-3-metoximetil-cef-3-em-4-carboxilico.
LT3871B (en) 1993-11-30 1996-04-25 Hoechst Ag Additive crystalline salts of pure diastereomers of 1-cefem-4-carboxylic acid 1-(2,2-dimethyl-propionyloxy)ethyl esters, process for the preparation thereof, pharmaceutical compositions and process for the preparation thereof
AT401651B (de) * 1994-06-14 1996-11-25 Biochemie Gmbh 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroximinoacetamido)-3-n,n- dimethylcarbamoyloxymethyl-3-cephem-4-
AT408226B (de) * 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
JP4749194B2 (ja) * 2006-03-28 2011-08-17 ジャパンパイル株式会社 オーガー削孔装置における土質試料採取具

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
US4668783A (en) * 1974-12-19 1987-05-26 Takeda Chemical Industries, Ltd. Thiazolylacetamido cephalosporin compounds
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
JPS5760345B2 (da) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
JPS523091A (en) * 1975-06-23 1977-01-11 Takeda Chem Ind Ltd A prcess for preparing cephalosporins
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
IT1101437B (it) * 1978-11-28 1985-09-28 Proter Spa Procedimento per il recupero di cefaloridina da soluzione acquosa nella quale e'stata prodotta
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4486425A (en) * 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
JPS5759894A (en) * 1980-09-30 1982-04-10 Sankyo Co Ltd Cephalosporin for oral administration
FR2532315A1 (fr) * 1982-08-27 1984-03-02 Rhone Poulenc Sante Formes cristallisees de sels d'addition avec des acides, de l'((amino-2-thiazolyl-4)-2 methoxyimino-2 acetamido)-7 carboxy-2 (dioxo-5,6 formylmethyl-4 tetrahydro-1,4,5,6 triazine-1,2,4 yl-3) thio-2 vinyl)-3 oxo-8 thia-5 aza-1 bicyclo(4.2.0) octene-2 isomere syn, forme e et leur preparation
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
DE3809561A1 (de) * 1988-03-22 1989-10-05 Hoechst Ag Ester der 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroxyiminoacetamido)-3-methoxymethyl-3-cephem-4-carbonsaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil

Also Published As

Publication number Publication date
FI96424B (fi) 1996-03-15
IE64076B1 (en) 1995-07-12
NO174258C (no) 1994-04-06
ZA904526B (en) 1991-03-27
JPH0730085B2 (ja) 1995-04-05
NO902607D0 (no) 1990-06-12
EP0402806B1 (de) 1993-09-29
KR0158883B1 (ko) 1998-12-01
US5409918A (en) 1995-04-25
NO902607L (no) 1990-12-14
CA2018794A1 (en) 1990-12-13
IL94701A (en) 1994-11-28
HUT56375A (en) 1991-08-28
PT94347B (pt) 1997-01-31
JPH0324086A (ja) 1991-02-01
ES2045653T3 (es) 1994-01-16
CA2018794C (en) 2000-05-16
DE3919259A1 (de) 1990-12-20
KR910000748A (ko) 1991-01-30
EP0402806A1 (de) 1990-12-19
PT94347A (pt) 1991-02-08
CN1048042A (zh) 1990-12-26
DE59002880D1 (de) 1993-11-04
IE902115L (en) 1990-12-13
AU5697690A (en) 1990-12-20
IE902115A1 (en) 1991-01-02
HU903828D0 (en) 1990-11-28
FI902900A0 (fi) 1990-06-11
HU207087B (en) 1993-03-01
NO174258B (no) 1993-12-27
DK0402806T3 (da) 1994-01-17
CN1043043C (zh) 1999-04-21
AU645254B2 (en) 1994-01-13
ATE95185T1 (de) 1993-10-15
FI96424C (fi) 1996-06-25
IL94701A0 (en) 1991-04-15

Similar Documents

Publication Publication Date Title
IE58487B1 (en) New cephalosporin compounds and the production thereof
US20080207912A1 (en) Method for manufacture of ceftiofur
RU2183212C2 (ru) Антибактериальные цефалоспорины, фармацевтическая композиция на их основе и способ лечения
FI108725B (fi) Menetelmä terapeuttisesti käyttökelpoisen (6R, 7R)-7-[2-(2aminotiatsol-4-yyli)-2(Z)-(metoksi-imino)asetamido]-3-(metoksimetyyli)-3-kefem-4-karbonihappo-1-(isopropoksikarbonyylioksi)etyyliesterin puhtaan, poolisemman diastereomeerin valmistamiseksi
EP0134420A1 (en) Cephalosporin derivatives, a process for their preparation and compositions containing them
JP3675863B2 (ja) セファロスポリン異性体の分離
NZ234004A (en) Crystalline, enterally absorbable salts of alpha-(2,2-dimethylpropanoyloxy)ethyl 7-(2-(2-aminothiazol-4-yl)-2-(z)-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate; pharmaceutical preparation and process for preparation
SK81597A3 (en) Production of cefotaxime and sodium salt thereof
FI108435B (fi) Menetelmõ terapeuttisesti kõytt÷kelpoisten 3-kefem-4-karboksyylihappo-1-(2,2-dimetyylipropionyylioksi)-etyyliesterin poolittomamman diastereomeerin kiteisten happoadditiosuolojen valmistamiseksi
KR900003563B1 (ko) 세팔로스포린 유도체의 제조방법
AU672056B2 (en) Cephalosporin salts and process for the preparation thereof
CZ9193A3 (en) Process for preparing hemiheptahydrate of disodium salt cefriaxon
KR840002046B1 (ko) 세팔로스포린의 제조방법
US4626533A (en) 7-(2-thienylacetamido)-3-acylaminomethyl-cephalosporins
EP0321562B1 (en) Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
KR100191120B1 (ko) 세펨유도체의 제조방법
KR100463920B1 (ko) 신규 세프디토렌 피복실 메지틸렌 설폰산염 및 그 제조방법
JPH01261391A (ja) セフェム誘導体
JPH0459781A (ja) セファロスポリン誘導体

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)